F. Rozen

发表

Identification of nuclear cap specific proteins in HeLa cells.

N. Sonenberg, F. Rozen, 1987, Nucleic acids research.

Gonadal steroid regulation of oxytocin and oxytocin receptor gene expression.

C. Breton, H. Zingg, C. Russo, 1995, Advances in experimental medicine and biology.

Oxytocin and oxytocin receptor gene expression in the uterus.

S. Richard, H. Zingg, D. Lefebvre, 1995, Recent progress in hormone research.

Survival of patients with breast cancer and BRCA1 mutations

W. Foulkes, J. Brunet, S. Narod, 1998, The Lancet.

Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment.

C. Breton, H. Zingg, C. Russo, 1995, Endocrinology.

Genomic and non-genomic mechanisms of oxytocin receptor regulation.

G. Guillon, C. Breton, B. Mouillac, 1998, Advances in experimental medicine and biology.

Structure, characterization, and expression of the rat oxytocin receptor gene.

D. Banville, H. Zingg, C. Russo, 1995, Proceedings of the National Academy of Sciences of the United States of America.

A lysine substitution in the ATP-binding site of eucaryotic initiation factor 4A abrogates nucleotide-binding activity

N. Sonenberg, J. Pelletier, H. Trachsel, 1989, Molecular and cellular biology.

Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.

M. Pollak, J. Zhang, F. Rozen, 1998, International journal of oncology.

Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.

M. Pollak, F. Rozen, 1999, International journal of oncology.

Structure, characterization, and expression of the rat oxytocin receptor gene (G-protein-coupled receptor/uterus/acute-phase response elements/initiation of labor)

H. Zingg, C. Russo, F. Rozen, 2016 .

Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F

N. Sonenberg, K. Meerovitch, I. Edery, 1990, Molecular and cellular biology.

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

L. Bégin, P. Chappuis, W. Foulkes, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

L. Bégin, W. Foulkes, P. Tonin, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.

M. Stampfer, B. Ge, C. Deal, 2001, The Journal of clinical endocrinology and metabolism.

Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.

H. Huynh, M. Pollak, F. Rozen, 1997, Journal of the National Cancer Institute.

Germ-Line BRCA 1 Mutation Is an Adverse Prognostic Factor in Ashkenazi Jewish Women with Breast Cancer 1

L. Bégin, W. Foulkes, P. Tonin, 2005 .